Bionik Laboratories Corp. financial data

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
80 Coolidge Hill Road, Watertown, MA
State of incorporation
DE
Fiscal year end
March 31
Former names
Drywave Technologies, Inc. (to 2/27/2015), Strategic Dental Management Corp. (to 6/19/2013)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 160 % +91.9%
Quick Ratio 60.9 % +338%
Debt-to-equity -34.8K % -4744%
Return On Equity 46.2K %
Return On Assets -133 % -1.54%
Operating Margin -267 % +65.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.5M shares +84.4%
Entity Public Float 1.37M USD +45.8%
Common Stock, Value, Issued 6.99K USD +1.6%
Weighted Average Number of Shares Outstanding, Basic 6.9M shares +18.1%
Weighted Average Number of Shares Outstanding, Diluted 6.9M shares +18.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.81M USD +41.7%
Cost of Revenue 815K USD +154%
Research and Development Expense 903K USD -9.54%
Selling and Marketing Expense 1.98M USD +3.18%
General and Administrative Expense 2.93M USD +4.39%
Operating Income (Loss) -4.83M USD +51.6%
Nonoperating Income (Expense) -32.8K USD +87.2%
Net Income (Loss) Attributable to Parent -4.95M USD +52.5%
Earnings Per Share, Basic -0.72 USD/shares +59.6%
Earnings Per Share, Diluted -0.72 USD/shares +59.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 427K USD -78.5%
Accounts Receivable, after Allowance for Credit Loss, Current 453K USD +64.9%
Inventory, Net 1.03M USD -13.1%
Assets, Current 2.78M USD -39.4%
Property, Plant and Equipment, Net 188K USD +106%
Operating Lease, Right-of-Use Asset 255K USD
Intangible Assets, Net (Excluding Goodwill) 34K USD
Goodwill 99.6K USD
Other Assets, Noncurrent 8.69K USD
Assets 3.36M USD -28.1%
Accounts Payable, Current 558K USD +82.8%
Employee-related Liabilities, Current 165K USD +42.1%
Accrued Liabilities, Current 1.39M USD +58.9%
Contract with Customer, Liability, Current 342K USD +9.08%
Liabilities, Current 2.31M USD +54.8%
Contract with Customer, Liability, Noncurrent 303K USD +18.2%
Operating Lease, Liability, Noncurrent 234K USD
Liabilities 5M USD +186%
Accumulated Other Comprehensive Income (Loss), Net of Tax 29.8K USD +6.12%
Retained Earnings (Accumulated Deficit) -100M USD -5.18%
Stockholders' Equity Attributable to Parent -1.64M USD -156%
Liabilities and Equity 3.36M USD -28.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.16M USD -88.1%
Net Cash Provided by (Used in) Financing Activities 500K USD -9.09%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 13M shares 0%
Common Stock, Shares, Issued 6.88M shares +1.64%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -663K USD -892%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 427K USD -78.5%
Operating Lease, Liability 257K USD
Depreciation 61K USD +52.5%
Payments to Acquire Property, Plant, and Equipment 0 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.94M USD +52.6%
Lessee, Operating Lease, Liability, to be Paid 330K USD
Property, Plant and Equipment, Gross 847K USD +22.8%
Operating Lease, Liability, Current 22.1K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 38.2K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 37K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 73.4K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 38.2K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 38.2K USD
Additional Paid in Capital 98.7M USD +0.38%
Amortization of Intangible Assets 1.58M USD +3.87%
Depreciation, Depletion and Amortization 11.3K USD -61%
Deferred Tax Assets, Net of Valuation Allowance 16.4M USD +3.88%
Share-based Payment Arrangement, Expense 300K USD -25%
Interest Expense 107K USD -87%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%